Radiometer America, Inc.

Radiometer America, Inc., a subsidiary of Danaher Corporation headquartered in Brea, California, manufactures and services blood gas analyzers, clinical laboratory instrumentation, and in-vitro diagnostic equipment as a prime contractor to federal healthcare agencies exclusively — the company holds no subcontract awards and competes full-and-open without set-aside designations. Radiometer America is classified as a foreign-owned for-profit manufacturer of goods under NAICS 325413 (In-Vitro Diagnostic Substance Manufacturing), 811210 (Electronic and Precision Equipment Repair and Maintenance), and related analytical and surgical instrument codes, with a federal award footprint spanning 2,572 prime contracts and indefinite delivery vehicles across 57 customer agencies since 1984.

The vendor's capability portfolio centers on point-of-care blood gas analyzers — particularly the ABL90 and ABL90 Flex Plus product lines — paired with reagents, maintenance services, software platforms (AQURE middleware and FlexLink connectivity), and field service support. Representative awards include a $933,417.28 purchase order from Veterans Integrated Service Network 8 for eight point-of-care blood gas analyzers, data management software, quality control materials, and on-site support across three Florida VA medical facilities (ultimate completion September 30, 2027); a $375,613.92 lease service contract from VISN 1 for three ABL90 analyzers with OEM maintenance at Boston VA Hospital (ultimate completion April 17, 2030); a $1,058,576.04 blanket purchase agreement from VISN 4 for blood gas testing services including equipment, reagents, maintenance, and clinical laboratory support across Pennsylvania and Delaware facilities (ultimate completion March 31, 2030); and a $71,830.43 sole-source definitive contract from VISN 17 for preventive maintenance and repair services on ABL90 analyzers under FAR 6.302-1 OEM authorization (ultimate completion June 30, 2029). Most recent activity includes a $77,706.92 purchase order from VISN 22 for ABL90 Flex Plus analyzers with Platinum Service including AQURE software, 24/7 remote troubleshooting, and same-day or next-business-day onsite response (awarded August 20, 2026, ultimate completion August 19, 2031).

Customer concentration sits heavily with the Department of Veterans Affairs regional networks, which collectively dominate both award count and dollar value. The top five customer agencies by award count cover 17 percent of all awards and are led by VISN 4 (116 awards, $15.6 million combined potential value) and VISN 12 (102 awards, $16.7 million combined potential value), followed by VISN 10, the Department of the Army Medical Command, and the VA central office. The top five customers by potential value cover 52 percent of combined potential value and track similarly, with VISN 12 ($16.7 million) and VISN 4 ($15.6 million) anchoring the stack, followed by VISN 2 ($10.6 million), VISN 22 ($3.8 million), and VISN 8 ($2.9 million). Beyond the VA, the vendor holds contracts with the Defense Health Agency (maintenance services at military treatment facilities including Fort Riley and Bassett Army Community Hospital), the Indian Health Service (CSU LAB ABL90 analyzer service at Crow Agency, Montana), and the Centers for Disease Control and Prevention. Recent activity has remained flat at six to eight awards per year across 2024–2026 after declining from 13 awards in 2022.

Radiometer America's vehicle position reflects the vendor's role as an equipment and supplies manufacturer rather than a services integrator. The company places work through three primary GSA Federal Supply Schedules — GS07F5598R (345 task orders, $11 million combined potential value), V797P6840A (323 task orders, $6.8 million combined potential value), and V797P4551A (301 task orders, $2.5 million combined potential value) — and holds a proprietary "Critical Analyzers, Laboratory" vehicle (560 task orders, $38.6 million combined potential value) that appears to be a specialized VA or multi-agency analytical instrument catalog. The vendor also holds multiple single-award blanket purchase agreements with individual VA VISNs, including the VISN 9 BPA ($393,390.06 ceiling through March 31, 2033, awarded April 1, 2026) and the VISN 4 BPA ($1,058,576.04 ceiling through March 31, 2030, awarded April 1, 2025). Within the next twenty-four months, ten awards carrying combined potential value of $1.8 million reach ultimate completion and face recompete risk, representing a limited near-term recompete cliff relative to the broader portfolio.

Award categorization reinforces the vendor's focus on diagnostic instrumentation and clinical laboratory support. The top three NAICS codes across the portfolio are Analytical Laboratory Instrument Manufacturing (428 awards), In-Vitro Diagnostic Substance Manufacturing (383 awards), and Surgical and Medical Instrument Manufacturing (325 awards); the PSC distribution mirrors this pattern with Medical and Surgical Instruments, Equipment, and Supplies (736 awards), Laboratory Equipment and Supplies (311 awards), and Reference Laboratory Testing (269 awards) dominating. All awards are issued on a full-and-open, non-set-aside basis at firm fixed price, with sole-source designations justified under FAR 6.302-1 (OEM authorization and proprietary parts access) appearing in recent VA contracts where Radiometer America is the only responsible source. The vendor's ownership as a Danaher subsidiary provides access to parent-company resources and positions Radiometer America within a broader diagnostics and life-sciences portfolio.